Bortezomib Injection is anti-cancer formulation which is known to work by inhibiting activity of proteasome. Active compound present in this injection has molecular formula C19H25BN4O4 with molar mass of 384.237 g/mol. It is administered via subcutaneous & IV route by skilled physician or doctor. This injection shows protein binding ability of about 83% with elimination half life of 9 to 15 hours. Bortezomib Injection is metabolized in liver with help of CYP enzymes. It exerts its activity by binding to 26S proteasome site with great affinity & specificity. It is available at highly competitive rates in bulk for our respected customers.
Cash in Advance (CID), Cash Advance (CA)
500 Per Month
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market
Other Products in 'Pharmaceutical Injection' You May Like